← Leaderboards
Jason Graham Gall
Genvec, Inc.
$1,689,371
Attributed
$1,689,371
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $545.8K · FY2008–13$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$1,689,371 · 3
By mechanism
R43$1,689,371 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Adenoviruses”
- David Heimbrook · Leidos Biomedical Research, Inc.$87,846,116
- Jaap Goudsmit · Beth Israel Deaconess Medical Center$53,211,886
- Larry Arthur$34,591,506
- Dan H. Barouch · Fred Hutchinson Cancer Center$34,036,726
- William George Nelson · Johns Hopkins University$30,145,983
- Daniel F. Hoft · Saint Louis University$29,294,132
Research focus
AdenovirusesGenerationsSmall Business Innovation Research GrantNeutralizing AntibodyVirusSafetyResearch Clinical TestingInfectionCell LineAnimal ModelVaccinesVectorAdenovirus VectorBaseSerotypingParticleRouteBiodistributionDoseTransgenesAttenuatedImmunizationImmune ResponseChild
Grant awards (6)
Adenovirus-vectored RSV vaccine not inhibited by maternal immunity$289,058
R43 · FY2013 · AI · contact PI
Adenovirus-vectored RSV vaccine not inhibited by maternal immunity$300,000
R43 · FY2012 · AI · contact PI
Development of an Ad14 Vaccine$254,536
R43 · FY2010 · AI · contact PI
Adenovirus Vectors for Respiratory Syncytial Virus Vaccination$300,000
R43 · FY2009 · AI · contact PI
Development of an Ad14 Vaccine$245,777
R43 · FY2009 · AI · contact PI
Adenovirus Vectors for Respiratory Syncytial Virus Vaccination$300,000
R43 · FY2008 · AI · contact PI